TP73 and ovarian carcinoma: In addition, high expression of TP73 was suggested in several kinds of human tumors such as breast cancer [15,16], esophageal cancer [17], thymic carcinoma [18], extrahepatic bile duct carcinoma [19], cholangiocellular carcinoma [20], hepatocellular carcinoma [21,22], gastric cancer [23,24], colorectal cancer [25–27], ovarian cancer [28], laryngeal cancer [29], parotid gland carcinoma [30], cutaneous melanoma [31] and retinoblastoma [32].